
Postdoc fellow @PORTAL_Research. @YaleLawSch '21; @ASU '18.
Joined October 2016
- Tweets53
- Following391
- Followers114
- Likes146
Joseph Daval retweeted
Big Pharma's legal arguments against price negotiation are absurd. Pharmaceutical manufacturers are not entitled to limitless profits at the expense of the American taxpayer. They should not abuse the legal system to stop the IRA's drug price provisions from going into effect.
My op-ed today in @washingtonpost with @akesselheim on the Medicare drug lawsuits: washingtonpost.com/opinions/…
Their arguments rely on the untenable premise that for-profit companies have a constitutionally protected right to receive taxpayer dollars.
Joseph Daval retweeted
Nice piece @DavalJoseph on protecting @CMSGov's coverage discretion: "A system in which taxpayers are required to pay for inferior treatments is not a competitive marketplace—it is an entitlement program for for-profit companies subsidized by the public" jamanetwork.com/journals/jam…
Joseph Daval retweeted
🔥 🔥 🔥 @JAMA_current viewpoint by @DavalJoseph @LiamBendicksen @akesselheim.
Protecting Medicare’s Discretion to Say No to Unproven Therapies
jamanetwork.com/journals/jam… – at Wellesley, MA
Joseph Daval retweeted
We had our annual @PORTAL_Research retreat yesterday! Always inspired by this group.
Looking forward to the year ahead in pharmaceutical policy!
Joseph Daval retweeted
Consistent alignment with advisory recommendations, along with an overall decrease in meetings, suggests that FDA is leaning away from independent expert advice even as it continues to follow it, according to this quality improvement study. ja.ma/3NGcsmr @akesselheim
Joseph Daval retweeted
The FDA has long conducted its oversight of prescription drugs and other products with deference from courts. But mounting judicial skepticism of agency authority threatens to upend this norm. nej.md/3J8jKx0
Joseph Daval retweeted
The FDA has long conducted its oversight of prescription drugs and other products with deference from courts. But mounting judicial skepticism of agency authority threatens to upend this norm. nej.md/3J8jKx0
Joseph Daval retweeted
Pleased to announce a recent small grant from the IBM Center for The Business of Government to support a comprehensive report on FDA Advisory Committee performance and reform led by @PORTAL_Research fellow @DavalJoseph coming in 2023: businessofgovernment.org/blo…
Joseph Daval retweeted
New from @DavalJoseph in @JAMAInternalMed - the Park doctrine is available to hold corporate officers directly responsible for fraud; why hasn't it been applied to more rx drug/med device cases?: jamanetwork.com/journals/jam…
Joseph Daval retweeted
The latest issue of @JLME_ASLME is now available, featuring "Immigration Law, Public Health, and the Future of Public Charge Policymaking," by @DavalJoseph. Please check it out! @PORTAL_Research @ASLMENews
cambridge.org/core/journals/…
Joseph Daval retweeted
Should FDA be an independent agency? In particular, should it be able to litigate independently w/o DOJ’s involvement?
@DavalJoseph: it’s complicated! DOJ limits FDA choices; distinct priorities; sometimes *more* enforcement. papers.ssrn.com/sol3/papers.…
#HLP22 @PORTAL_Research
Joseph Daval retweeted
Presenting new work this afternoon @ASLMENews #HLP22
I'm on a panel with @WNicholsonPrice @UMichLaw, @gerke_sara @DickinsonLaw & @DavalJoseph @PORTAL_Research. Join us as we take a deep dive into the nuances of FDA law and policy!
Joseph Daval retweeted
At #HLP22 @ASLMENews, PORTAL fellow @DavalJoseph presents "Independence & Influence in FDA Decisionmaking"
Joseph Daval retweeted
In their new Health Affairs paper,@DavalJoseph of @BrighamWomens & @Harvard and coauthors examine the 482 new drugs and biologics approved by the @US_FDA between 2010-21, with a particular focus on the 10 drugs approved despite a negative advisory committee vote. #Pharmaceuitcals
Joseph Daval retweeted
From 2010-21, the amount of FDA-approved drugs that had been referred to an advisory committee decreased from 55% to 6% annually, report #FSP Alum @akesselheim @DavalJoseph & @AmeetSarpatwari in @Health_Affairs. healthaffairs.org/doi/10.137…
Joseph Daval retweeted
Great new piece from Harvard's @PORTAL_Research group. FDA has moved (massively) away from Advisory Committees. @statnews story: statnews.com/pharmalot/2022/… @Health_Affairs article: healthaffairs.org/doi/10.137… Is it - If you don't care about advice you may get, don't ask for it?
Joseph Daval retweeted
"Our study found inconsistency at every stage in the advisory committee process," Joseph Daval, one of the authors of the analysis. buff.ly/3s8XoDT
Joseph Daval retweeted
In his new blog, @DavalJoseph from @PORTAL_Research argues that by rescinding Trump’s #PublicCharge Rule, the Biden administration must now decide how it will interpret the same underlying law, which excludes immigrants likely to become a “public charge.” https://nitter.gq/t.co/PJ95X8Hj0y
Joseph Daval retweeted
And you can read @DavalJoseph’s student category piece, “The Problem with Public Charge”, at https://nitter.gq/t.co/g07IQzehya Congrats, Joseph!




























